摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-cyclopentyl-2-(1-methoxy-ethyl)-7,7-dimethyl-3-(4-trifluoromethyl-benzoyl)-7,8-dihydro-6H-quinolin-5-one | 1186525-04-1

中文名称
——
中文别名
——
英文名称
4-cyclopentyl-2-(1-methoxy-ethyl)-7,7-dimethyl-3-(4-trifluoromethyl-benzoyl)-7,8-dihydro-6H-quinolin-5-one
英文别名
4-cyclopentyl-2-(1-methoxyethyl)-7,7-dimethyl-3-[4-(trifluoromethyl)benzoyl]-6,8-dihydroquinolin-5-one
4-cyclopentyl-2-(1-methoxy-ethyl)-7,7-dimethyl-3-(4-trifluoromethyl-benzoyl)-7,8-dihydro-6H-quinolin-5-one化学式
CAS
1186525-04-1
化学式
C27H30F3NO3
mdl
——
分子量
473.535
InChiKey
RSGFSXDXWSBUCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    34
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    56.3
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
    申请人:Wagner Holger
    公开号:US08703793B2
    公开(公告)日:2014-04-22
    Compounds of formula (I) wherein the groups R1 to R8 have the meanings indicated in the description, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof have valuable pharmacological properties, which make them useful for the treatment of cardiovascular and related disorders.
    化合物的公式(I),其中基团R1到R8具有说明中所示的含义,其互变异构体、立体异构体、混合物和盐具有有价值的药理学性质,使其用于治疗心血管和相关疾病。
  • TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2268644B1
    公开(公告)日:2011-08-17
  • US8703793B2
    申请人:——
    公开号:US8703793B2
    公开(公告)日:2014-04-22
  • [EN] TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION<br/>[FR] DÉRIVÉS DE PYRIDINES TRICYCLIQUES, MÉDICAMENTS CONTENANT CES COMPOSÉS, LEUR UTILISATION ET LEUR PROCÉDÉ DE PRÉPARATION
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2009109549A1
    公开(公告)日:2009-09-11
    Compounds of formula (I) wherein the groups R1 to R8 have the meanings indicated in the description, the tautomers.the stereoisomers.the mixtures thereof and the salts thereof have valuable pharmacological properties.which make them useful for the treatment of cardiovascular and related disorders.
    式(I)中的化合物,其中基团R1至R8具有描述中所指的含义,其互变异构体、立体异构体、混合物及其盐具有有价值的药理特性,使它们在治疗心血管及相关疾病方面具有用途。
查看更多